Imatinib front-line therapy is safe and effective in patients with chronic myelogenous leukemia with pre-existing liver and/or renal dysfunction (Q33390293)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib front-line therapy is safe and effective in patients with chronic myelogenous leukemia with pre-existing liver and/or renal dysfunction |
scientific article |
Statements
1 reference
Imatinib front-line therapy is safe and effective in patients with chronic myelogenous leukemia with pre-existing liver and/or renal dysfunction (English)
1 reference
Hagop Kantarjian
1 reference
Stefan Faderl
1 reference
Jorge Cortes
1 reference
Susan O'Brien
1 reference
Farhad Ravandi
1 reference
Gautam Borthakur
1 reference
Mary Beth Rios
1 reference
Sherry Pierce
1 reference
Wei-Gang Tong
1 reference
Jianqin Shan
1 reference
1 July 2010
1 reference
1 reference
116
1 reference
13
1 reference
3152-3159
1 reference
Identifiers
1 reference
1 reference
1 reference